Causes of death and rehospitalization in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: results from Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) program

Causes of death and rehospitalization in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: results from Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) program / O'Connor, Cm; Miller, Ab; Blair, Je; Konstam, Ma; Wedge, P; Bahit, Mc; Carson, P; Haass, M; Hauptman, Pj; Metra, Marco; Oren, Rm; Patten, R; Piña, I; Roth, S; Sackner Bernstein, Jd; Traver, B; Cook, T; Gheorghiade, M.. - In: AMERICAN HEART JOURNAL. - ISSN 0002-8703. - 159(5):(2010), pp. 841-849.